Comparative analysis of C9Orf72 and sporadic disease in a large multicenter ALS population

The effect of Male sex on survival of C9Orf72 positive patients

Francesca Trojsi, Mattia Siciliano, Cinzia Femiano, Gabriella Santangelo, Christian Lunetta, Andrea Calvo, Cristina Moglia, Kalliopi Marinou, Nicola Ticozzi, Christian Ferro, Carlo Scialò, Gianni Sorarù, Amelia Conte, Yuri M. Falzone, Rosanna Tortelli, Massimo Russo, Valeria Ada Sansone, Adriano Chiò, Gabriele Mora, Vincenzo Silani & 11 others Paolo Volanti, Claudia Caponnetto, Giorgia Querin, Mario Sabatelli, Nilo Riva, Giancarlo Logroscino, Sonia Messina, Antonio Fasano, Maria Rosaria Monsurrò, Gioacchino Tedeschi, Jessica Mandrioli

Research output: Contribution to journalArticle

Abstract

We investigated whether the C9orf72 repeat expansion is associated with specific clinical features, comorbidities, and prognosis in patients with amyotrophic lateral sclerosis (ALS). A cohort of 1417 ALS patients, diagnosed between January 1, 2009 and December 31, 2013 by 13 Italian ALS Referral Centers, was screened for the C9orf72 repeat expansion, and the analyses were performed comparing patients carrying this expansion (ALS-C9Pos) to those negative for this and other explored ALS-related mutations (ALS without genetic mutations, ALSwoGM). Compared to the ALSwoGM group, ALS-C9Pos patients (n = 84) were younger at disease onset, at the first clinical observation and at diagnosis (p < 0.001). After correcting for these differences, we found that ALS-C9Pos patients had higher odds of bulbar onset, diagnosis of frontotemporal dementia (FTD) and family history of ALS, FTD, and Alzheimer's disease and had lower odds of spinal onset, non-invasive ventilation, hypertension and psychiatric diseases than ALSwoGM patients. Among these variables, those related to shorter survival time were: bulbar onset, presence of FTD, hypertension, psychiatric disease, and family history of ALS (p < 0.05). Cox proportional hazards regression multivariate analysis suggested that carrying the C9orf72 repeat expansion was an independent factor negatively impacting on survival time in men (HR 1.58, 95% CI 1.07-2.33, p = 0.021), but not in women (p > 0.05) as well as in the whole sample (p > 0.05). When compared to ALSwoGM, ALS-C9Pos showed an earlier disease onset, no significant diagnostic delay and a higher odds of bulbar onset, FTD and family history of ALS and dementia. Moreover, male sex drove the negative effect of expanded variant on survival, confirming the hypothesis that sex is likely to be a crucial factor in the biology of C9orf72-related disease.

Original languageEnglish
Article number485
JournalFrontiers in Neuroscience
Volume13
Issue numberMAY
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Amyotrophic Lateral Sclerosis
Survival
Population
Mutation
Dementia
Comorbidity
Referral and Consultation
Observation

Keywords

  • Amyotrophic lateral sclerosis
  • C9orf72 expansion
  • Comorbidity
  • Gender
  • Survival

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Comparative analysis of C9Orf72 and sporadic disease in a large multicenter ALS population : The effect of Male sex on survival of C9Orf72 positive patients. / Trojsi, Francesca; Siciliano, Mattia; Femiano, Cinzia; Santangelo, Gabriella; Lunetta, Christian; Calvo, Andrea; Moglia, Cristina; Marinou, Kalliopi; Ticozzi, Nicola; Ferro, Christian; Scialò, Carlo; Sorarù, Gianni; Conte, Amelia; Falzone, Yuri M.; Tortelli, Rosanna; Russo, Massimo; Sansone, Valeria Ada; Chiò, Adriano; Mora, Gabriele; Silani, Vincenzo; Volanti, Paolo; Caponnetto, Claudia; Querin, Giorgia; Sabatelli, Mario; Riva, Nilo; Logroscino, Giancarlo; Messina, Sonia; Fasano, Antonio; Monsurrò, Maria Rosaria; Tedeschi, Gioacchino; Mandrioli, Jessica.

In: Frontiers in Neuroscience, Vol. 13, No. MAY, 485, 01.01.2019.

Research output: Contribution to journalArticle

Trojsi, F, Siciliano, M, Femiano, C, Santangelo, G, Lunetta, C, Calvo, A, Moglia, C, Marinou, K, Ticozzi, N, Ferro, C, Scialò, C, Sorarù, G, Conte, A, Falzone, YM, Tortelli, R, Russo, M, Sansone, VA, Chiò, A, Mora, G, Silani, V, Volanti, P, Caponnetto, C, Querin, G, Sabatelli, M, Riva, N, Logroscino, G, Messina, S, Fasano, A, Monsurrò, MR, Tedeschi, G & Mandrioli, J 2019, 'Comparative analysis of C9Orf72 and sporadic disease in a large multicenter ALS population: The effect of Male sex on survival of C9Orf72 positive patients', Frontiers in Neuroscience, vol. 13, no. MAY, 485. https://doi.org/10.3389/fnins.2019.00485
Trojsi, Francesca ; Siciliano, Mattia ; Femiano, Cinzia ; Santangelo, Gabriella ; Lunetta, Christian ; Calvo, Andrea ; Moglia, Cristina ; Marinou, Kalliopi ; Ticozzi, Nicola ; Ferro, Christian ; Scialò, Carlo ; Sorarù, Gianni ; Conte, Amelia ; Falzone, Yuri M. ; Tortelli, Rosanna ; Russo, Massimo ; Sansone, Valeria Ada ; Chiò, Adriano ; Mora, Gabriele ; Silani, Vincenzo ; Volanti, Paolo ; Caponnetto, Claudia ; Querin, Giorgia ; Sabatelli, Mario ; Riva, Nilo ; Logroscino, Giancarlo ; Messina, Sonia ; Fasano, Antonio ; Monsurrò, Maria Rosaria ; Tedeschi, Gioacchino ; Mandrioli, Jessica. / Comparative analysis of C9Orf72 and sporadic disease in a large multicenter ALS population : The effect of Male sex on survival of C9Orf72 positive patients. In: Frontiers in Neuroscience. 2019 ; Vol. 13, No. MAY.
@article{f788ea45ea3743ac90991e2d03d4693e,
title = "Comparative analysis of C9Orf72 and sporadic disease in a large multicenter ALS population: The effect of Male sex on survival of C9Orf72 positive patients",
abstract = "We investigated whether the C9orf72 repeat expansion is associated with specific clinical features, comorbidities, and prognosis in patients with amyotrophic lateral sclerosis (ALS). A cohort of 1417 ALS patients, diagnosed between January 1, 2009 and December 31, 2013 by 13 Italian ALS Referral Centers, was screened for the C9orf72 repeat expansion, and the analyses were performed comparing patients carrying this expansion (ALS-C9Pos) to those negative for this and other explored ALS-related mutations (ALS without genetic mutations, ALSwoGM). Compared to the ALSwoGM group, ALS-C9Pos patients (n = 84) were younger at disease onset, at the first clinical observation and at diagnosis (p < 0.001). After correcting for these differences, we found that ALS-C9Pos patients had higher odds of bulbar onset, diagnosis of frontotemporal dementia (FTD) and family history of ALS, FTD, and Alzheimer's disease and had lower odds of spinal onset, non-invasive ventilation, hypertension and psychiatric diseases than ALSwoGM patients. Among these variables, those related to shorter survival time were: bulbar onset, presence of FTD, hypertension, psychiatric disease, and family history of ALS (p < 0.05). Cox proportional hazards regression multivariate analysis suggested that carrying the C9orf72 repeat expansion was an independent factor negatively impacting on survival time in men (HR 1.58, 95{\%} CI 1.07-2.33, p = 0.021), but not in women (p > 0.05) as well as in the whole sample (p > 0.05). When compared to ALSwoGM, ALS-C9Pos showed an earlier disease onset, no significant diagnostic delay and a higher odds of bulbar onset, FTD and family history of ALS and dementia. Moreover, male sex drove the negative effect of expanded variant on survival, confirming the hypothesis that sex is likely to be a crucial factor in the biology of C9orf72-related disease.",
keywords = "Amyotrophic lateral sclerosis, C9orf72 expansion, Comorbidity, Gender, Survival",
author = "Francesca Trojsi and Mattia Siciliano and Cinzia Femiano and Gabriella Santangelo and Christian Lunetta and Andrea Calvo and Cristina Moglia and Kalliopi Marinou and Nicola Ticozzi and Christian Ferro and Carlo Scial{\`o} and Gianni Sorar{\`u} and Amelia Conte and Falzone, {Yuri M.} and Rosanna Tortelli and Massimo Russo and Sansone, {Valeria Ada} and Adriano Chi{\`o} and Gabriele Mora and Vincenzo Silani and Paolo Volanti and Claudia Caponnetto and Giorgia Querin and Mario Sabatelli and Nilo Riva and Giancarlo Logroscino and Sonia Messina and Antonio Fasano and Monsurr{\`o}, {Maria Rosaria} and Gioacchino Tedeschi and Jessica Mandrioli",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fnins.2019.00485",
language = "English",
volume = "13",
journal = "Frontiers in Neuroscience",
issn = "1662-4548",
publisher = "Frontiers Media S.A.",
number = "MAY",

}

TY - JOUR

T1 - Comparative analysis of C9Orf72 and sporadic disease in a large multicenter ALS population

T2 - The effect of Male sex on survival of C9Orf72 positive patients

AU - Trojsi, Francesca

AU - Siciliano, Mattia

AU - Femiano, Cinzia

AU - Santangelo, Gabriella

AU - Lunetta, Christian

AU - Calvo, Andrea

AU - Moglia, Cristina

AU - Marinou, Kalliopi

AU - Ticozzi, Nicola

AU - Ferro, Christian

AU - Scialò, Carlo

AU - Sorarù, Gianni

AU - Conte, Amelia

AU - Falzone, Yuri M.

AU - Tortelli, Rosanna

AU - Russo, Massimo

AU - Sansone, Valeria Ada

AU - Chiò, Adriano

AU - Mora, Gabriele

AU - Silani, Vincenzo

AU - Volanti, Paolo

AU - Caponnetto, Claudia

AU - Querin, Giorgia

AU - Sabatelli, Mario

AU - Riva, Nilo

AU - Logroscino, Giancarlo

AU - Messina, Sonia

AU - Fasano, Antonio

AU - Monsurrò, Maria Rosaria

AU - Tedeschi, Gioacchino

AU - Mandrioli, Jessica

PY - 2019/1/1

Y1 - 2019/1/1

N2 - We investigated whether the C9orf72 repeat expansion is associated with specific clinical features, comorbidities, and prognosis in patients with amyotrophic lateral sclerosis (ALS). A cohort of 1417 ALS patients, diagnosed between January 1, 2009 and December 31, 2013 by 13 Italian ALS Referral Centers, was screened for the C9orf72 repeat expansion, and the analyses were performed comparing patients carrying this expansion (ALS-C9Pos) to those negative for this and other explored ALS-related mutations (ALS without genetic mutations, ALSwoGM). Compared to the ALSwoGM group, ALS-C9Pos patients (n = 84) were younger at disease onset, at the first clinical observation and at diagnosis (p < 0.001). After correcting for these differences, we found that ALS-C9Pos patients had higher odds of bulbar onset, diagnosis of frontotemporal dementia (FTD) and family history of ALS, FTD, and Alzheimer's disease and had lower odds of spinal onset, non-invasive ventilation, hypertension and psychiatric diseases than ALSwoGM patients. Among these variables, those related to shorter survival time were: bulbar onset, presence of FTD, hypertension, psychiatric disease, and family history of ALS (p < 0.05). Cox proportional hazards regression multivariate analysis suggested that carrying the C9orf72 repeat expansion was an independent factor negatively impacting on survival time in men (HR 1.58, 95% CI 1.07-2.33, p = 0.021), but not in women (p > 0.05) as well as in the whole sample (p > 0.05). When compared to ALSwoGM, ALS-C9Pos showed an earlier disease onset, no significant diagnostic delay and a higher odds of bulbar onset, FTD and family history of ALS and dementia. Moreover, male sex drove the negative effect of expanded variant on survival, confirming the hypothesis that sex is likely to be a crucial factor in the biology of C9orf72-related disease.

AB - We investigated whether the C9orf72 repeat expansion is associated with specific clinical features, comorbidities, and prognosis in patients with amyotrophic lateral sclerosis (ALS). A cohort of 1417 ALS patients, diagnosed between January 1, 2009 and December 31, 2013 by 13 Italian ALS Referral Centers, was screened for the C9orf72 repeat expansion, and the analyses were performed comparing patients carrying this expansion (ALS-C9Pos) to those negative for this and other explored ALS-related mutations (ALS without genetic mutations, ALSwoGM). Compared to the ALSwoGM group, ALS-C9Pos patients (n = 84) were younger at disease onset, at the first clinical observation and at diagnosis (p < 0.001). After correcting for these differences, we found that ALS-C9Pos patients had higher odds of bulbar onset, diagnosis of frontotemporal dementia (FTD) and family history of ALS, FTD, and Alzheimer's disease and had lower odds of spinal onset, non-invasive ventilation, hypertension and psychiatric diseases than ALSwoGM patients. Among these variables, those related to shorter survival time were: bulbar onset, presence of FTD, hypertension, psychiatric disease, and family history of ALS (p < 0.05). Cox proportional hazards regression multivariate analysis suggested that carrying the C9orf72 repeat expansion was an independent factor negatively impacting on survival time in men (HR 1.58, 95% CI 1.07-2.33, p = 0.021), but not in women (p > 0.05) as well as in the whole sample (p > 0.05). When compared to ALSwoGM, ALS-C9Pos showed an earlier disease onset, no significant diagnostic delay and a higher odds of bulbar onset, FTD and family history of ALS and dementia. Moreover, male sex drove the negative effect of expanded variant on survival, confirming the hypothesis that sex is likely to be a crucial factor in the biology of C9orf72-related disease.

KW - Amyotrophic lateral sclerosis

KW - C9orf72 expansion

KW - Comorbidity

KW - Gender

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85068535656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068535656&partnerID=8YFLogxK

U2 - 10.3389/fnins.2019.00485

DO - 10.3389/fnins.2019.00485

M3 - Article

VL - 13

JO - Frontiers in Neuroscience

JF - Frontiers in Neuroscience

SN - 1662-4548

IS - MAY

M1 - 485

ER -